# Hepta Medical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/hepta-medical

- Industry: Medical Devices & Equipment
- Headquarters: Suresnes, France
- Website: www.heptamed.com
- Total disclosed funding: $11M
- Latest round: Series A (Mar 31, 2026)
- Investors on record: 7

## About

Founded in 2018 and based in France, Hepta Medical is a medical device manufacturing company that develops a micro-wave ablation catheter with integrated tissue temperature sensing to allow for real-time monitoring of tissue ablation. As of June 2026 Thomas Bancel is the CEO of the company. In March 2026, Hepta Medical raised EUR 4.3 million in series A funding from UI Investissement and Supernova Invest with participation from MD Start SA, M&L Healthcare, Clery and Bpifrance Investissement. This round was a larger part of EUR 10 million series A and series A extension funding.

The company develops a microwave ablation catheter that integrates tissue temperature sensing technology that allows for real-time monitoring of tissue ablation. The firm empowers medical professionals to perform ablations while controlling the size of the lesion by leveraging its technology. Hepta Medical’s precision translates into improved efficiency and safety outcomes for patients.

The company may use the March 2026 Series A funding to support the organization's product approval.

## Funding rounds

- Series A, Mar 31, 2026, $5M — UI Investissement, Md Start Ii Sas, Bpifrance Investissement, Supernova Invest, M&L Healthcare, Clery
- Series A, Sep 4, 2024, $6.3M — CDC Enterprises, M&L Healthcare, Clery

## Investors

- CDC Enterprises (https://capitalatlas.ai/funds/cdc-enterprises) — Series A
- M&L Healthcare — Series A
- Clery — Series A
- UI Investissement (https://capitalatlas.ai/funds/ui-investissement) — Series A
- Md Start Ii Sas — Series A
- Bpifrance Investissement (https://capitalatlas.ai/funds/bpifrance-investissement) — Series A
- Supernova Invest (https://capitalatlas.ai/funds/supernova-invest) — Series A